Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
5iub | CLR | Adenosine receptor A2a |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
5iub | CLR | Adenosine receptor A2a | / | 1.000 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.784 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.772 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.703 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.693 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.672 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.658 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.656 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.651 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.641 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.640 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.635 | |
4ug2 | NGI | Adenosine receptor A2a | / | 0.570 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.538 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.517 | |
5g53 | NEC | Adenosine receptor A2a | / | 0.510 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.506 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.500 | |
1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.493 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.490 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.489 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.481 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.481 | |
4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.481 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.480 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.480 | |
4g95 | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.479 | |
5dp2 | NAP | CurF | / | 0.479 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.478 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.477 | |
1upw | 444 | Oxysterols receptor LXR-beta | / | 0.477 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.475 | |
4ejn | 0R4 | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.475 | |
2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.473 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.473 | |
1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.471 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.471 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.471 | |
1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.470 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.470 | |
3tda | PN0 | Cytochrome P450 2D6 | / | 0.470 | |
4b4v | L34 | Bifunctional protein FolD | / | 0.470 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.470 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.469 | |
1a4i | NDP | C-1-tetrahydrofolate synthase, cytoplasmic | 1.5.1.5 | 0.468 | |
1fmj | RTL | Retinol dehydratase | / | 0.468 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.468 | |
3lpf | Z77 | Beta-glucuronidase | 3.2.1.31 | 0.468 | |
4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.468 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.467 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.466 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.466 | |
3slk | NDP | Polyketide synthase extender module 2 | / | 0.466 | |
3qak | UKA | Adenosine receptor A2a | / | 0.466 | |
2e98 | B29 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.465 | |
2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.465 | |
2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.465 | |
1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.464 | |
2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.463 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.463 | |
3kpk | FAD | Sulfide-quinone reductase | / | 0.463 | |
1hsk | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.462 | |
3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.462 | |
4pd6 | URI | Nucleoside permease | / | 0.462 | |
3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.461 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.460 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.460 | |
1ia4 | TQ6 | Dihydrofolate reductase | 1.5.1.3 | 0.459 | |
1siq | FAD | Glutaryl-CoA dehydrogenase, mitochondrial | 1.3.8.6 | 0.459 | |
3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.459 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.459 | |
4at0 | FAD | Possible succinate dehydrogenase | / | 0.459 | |
2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.458 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.458 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.458 | |
3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.458 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.458 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.457 | |
1osv | CHC | Bile acid receptor | / | 0.457 | |
2ic5 | GNP | Ras-related C3 botulinum toxin substrate 3 | / | 0.457 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.457 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.457 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
1iyz | NDP | Probable quinone oxidoreductase | / | 0.456 | |
1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.456 | |
2ivn | ANP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.456 | |
2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.456 | |
3u8h | BHP | Phospholipase A2, membrane associated | / | 0.456 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.456 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.456 | |
1e2j | THM | Thymidine kinase | / | 0.455 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.455 | |
3fnh | JPJ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.455 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.455 | |
2bel | CBO | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.454 | |
2c59 | NAD | GDP-mannose 3,5-epimerase | 5.1.3.18 | 0.454 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.454 | |
3zku | HCV | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.454 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.454 | |
1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.453 | |
1xkd | NAP | Isocitrate dehydrogenase [NADP] | / | 0.453 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
3ggp | NAD | Prephenate dehydrogenase | / | 0.453 | |
3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
4a81 | DXC | Major pollen allergen Bet v 1-A | / | 0.453 | |
1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.452 | |
1g6o | ADP | Cag alpha | / | 0.452 | |
1w7h | 3IP | Mitogen-activated protein kinase 14 | / | 0.452 | |
2fsz | OHT | Estrogen receptor beta | / | 0.452 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.452 | |
4wa9 | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.452 | |
1qjf | ACS | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.450 | |
1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
1qkn | RAL | Estrogen receptor beta | / | 0.450 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
3t14 | FAD | Sulfide-quinone reductase | / | 0.450 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.450 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.450 | |
4okx | 198 | Androgen receptor | / | 0.450 | |
1fml | RTL | Retinol dehydratase | / | 0.449 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.449 | |
1rk3 | VDX | Vitamin D3 receptor | / | 0.449 | |
1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.449 | |
3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.449 | |
4i8v | BHF | Cytochrome P450 1A1 | 1.14.14.1 | 0.449 | |
4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
1e92 | HBI | Pteridine reductase 1 | 1.5.1.33 | 0.448 | |
2bfm | TOP | Pteridine reductase 1 | 1.5.1.33 | 0.448 | |
2has | C3O | Vitamin D3 receptor | / | 0.448 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
4a83 | DXC | Major pollen allergen Bet v 1-A | / | 0.448 | |
4bc7 | FAD | Alkyldihydroxyacetonephosphate synthase, peroxisomal | 2.5.1.26 | 0.448 | |
4bfy | ZVY | Pantothenate kinase | 2.7.1.33 | 0.448 | |
4ej1 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
1crb | RTL | Retinol-binding protein 1 | / | 0.447 | |
3ha5 | SFG | Hydroxymycolate synthase MmaA4 | 2.1.1 | 0.447 | |
4c2j | COA | 3-ketoacyl-CoA thiolase, mitochondrial | 2.3.1.16 | 0.447 | |
5hbs | RTL | Retinol-binding protein 1 | / | 0.447 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.446 | |
1rgs | CMP | cAMP-dependent protein kinase type I-alpha regulatory subunit | / | 0.446 | |
2ar8 | FAD | Flavin-dependent tryptophan halogenase PrnA | 1.14.19.9 | 0.446 | |
2bf7 | HBI | Pteridine reductase 1 | 1.5.1.33 | 0.446 | |
2g0n | GDP | Ras-related C3 botulinum toxin substrate 3 | / | 0.446 | |
2zb8 | IMN | Prostaglandin reductase 2 | 1.3.1.48 | 0.446 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
4lb2 | DM5 | Serum albumin | / | 0.446 | |
4z9r | NAD | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.446 | |
2azy | CHD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.445 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
4b4w | 9L9 | Bifunctional protein FolD | / | 0.445 | |
4l23 | X6K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.445 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.445 | |
5doz | NDP | JamJ | / | 0.445 | |
1qyx | ASD | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.444 | |
2cvz | NDP | 3-hydroxyisobutyrate dehydrogenase | / | 0.444 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
3a78 | 3EV | Vitamin D3 receptor | / | 0.444 | |
3bgx | MEF | Thymidylate synthase | / | 0.444 | |
3g5s | FAD | Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO | / | 0.444 | |
3h4v | DVP | Pteridine reductase 1 | 1.5.1.33 | 0.444 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.444 | |
3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.444 | |
3t2k | FAD | Sulfide-quinone reductase | / | 0.444 | |
4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.444 | |
1q0r | AKT | Aclacinomycin methylesterase RdmC | 3.1.1.95 | 0.443 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
3w0j | T08 | Vitamin D3 receptor | / | 0.443 | |
3wv9 | FEG | Hmd co-occurring protein HcgE | / | 0.443 | |
3zcn | ATP | Adenosine monophosphate-protein transferase SoFic | 2.7.7.n1 | 0.443 | |
4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.443 | |
1err | RAL | Estrogen receptor | / | 0.442 | |
1mrq | STR | Aldo-keto reductase family 1 member C1 | / | 0.442 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
2dvl | FAD | Acyl-CoA dehydrogenase | / | 0.442 | |
2rbe | NDP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
3up0 | D7S | aceDAF-12 | / | 0.442 | |
3v94 | WYQ | Phosphodiesterase | / | 0.442 | |
3vtb | TKA | Vitamin D3 receptor | / | 0.442 | |
4at5 | MUJ | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.442 | |
4bb6 | HD1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.442 | |
4qbj | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.442 | |
4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.442 | |
5dc5 | B3N | Histone deacetylase 8 | 3.5.1.98 | 0.442 | |
3rey | XAC | Adenosine receptor A2a | / | 0.442 | |
1e1n | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.441 | |
1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.441 | |
3a1l | 2CC | Cytochrome P450 | / | 0.441 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
3oqk | S52 | Renin | 3.4.23.15 | 0.441 | |
3q9t | FAY | Uncharacterized protein | / | 0.441 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
3wav | DWV | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 3.1.4.39 | 0.441 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
4h95 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
4jqh | 1MF | Alr2278 protein | / | 0.441 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.441 | |
1ezv | SMA | Cytochrome b | / | 0.440 | |
1gnw | GTX | Glutathione S-transferase F2 | 2.5.1.18 | 0.440 | |
1kb9 | SMA | Cytochrome b | / | 0.440 | |
1kyo | SMA | Cytochrome b | / | 0.440 | |
1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.440 | |
1pz1 | NAP | General stress protein 69 | / | 0.440 | |
1qyw | 5SD | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.440 | |
1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.440 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.440 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
2o4r | VD5 | Vitamin D3 receptor | / | 0.440 | |
3g4l | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.440 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
4nie | NBH | Nuclear receptor ROR-gamma | / | 0.440 | |
5fsx | ADP | Uncharacterized protein | / | 0.440 |